Cited by 328Cannabis and Cannabinoid ResearchReceptor Mechanisms and SignalingNeuropeptides and Animal Physiology

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

μ opioid and CB1 cannabinoid receptor interactions: reciprocal inhibition of receptor signaling and neuritogenesis

Open access

Rios, Carl, Gomes, Ivone, Devi, Lakshmi A·2006·British Journal of Pharmacology

DOI 10.1038/sj.bjp.0706757PMC PMC1751792

Open this paper in CoChat — free account Open PDF

Abstract

Several studies have described functional interactions between opioid and cannabinoid receptors; the underlying mechanism(s) have not been well explored. One possible mechanism is direct receptor–receptor interactions, as has been demonstrated for a number of G‐protein‐coupled receptors. In order to investigate interactions between opioid and cannabinoid receptors, we epitope tagged μ, δ and κ opioid receptors with Renilla luciferase and CB1 cannabinoid or CCR5 chemokine receptors with yellow fluorescent protein and examined the extent of substrate hydrolysis induced bioluminescence resonance energy transfer (BRET) signal. We find that coexpression of opioid receptors with cannabinoid receptors, but not with chemokine receptors, leads to a significant increase in the level of BRET signal, suggesting that the opioid–cannabinoid interactions are receptor specific. In order to examine the implications of these interactions to signaling, we used GTP γ S binding and mitogen‐activated protein kinase (MAPK) phosphorylation assays and examined the effect of receptor activation on signaling. We find that the μ receptor‐mediated signaling is attenuated by the CB1 receptor agonist; this effect is reciprocal and is seen in heterologous cells and endogenous tissue expressing both receptors. In order to explore the physiological consequences of this interaction, we examined the effect of receptor activation on the extent of Src and STAT3 phosphorylation and neuritogenesis in Neuro‐2A cells. We find that the simultaneous activation of μ opioid and CB1 cannabinoid receptors leads to a significant attenuation of the response seen upon activation of individual receptors, implicating a role for receptor–receptor interactions in modulating neuritogenesis. British Journal of Pharmacology (2006) 148, 387–395. doi:10.1038/sj.bjp.0706757

Integrity signals

Registry

Crossref · 10.1038/sj.bjp.0706757

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Unresponsiveness to Cannabinoids and Reduced Addictive Effects of Opiates in CB 1 Receptor Knockout Mice
Ledent, C. A., Valverde, O., Cossu, G., Petitet, F., Aubert, J.-F., Beslot, F., Böhme, G. A., Impérato, A., Pedrazzini, T., Roques, B. P., et al. (1999) · Science · doi:10.1126/science.283.5400.401 · Cited by 3,618
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor
KUNISHIMA, N., Shimada, Y., Tsuji, Y., Sato, T., Yamamoto, M., Kumasaka, T., Nakanishi, S., Jingami, H., & Morikawa, K. (2000) · Nature · doi:10.1038/35039564 · Cited by 1,249
Heterodimerization is required for the formation of a functional GABAB receptor
White, J. H. M., Wise, A., Main, M. J., Green, A., Fraser, N. J., Disney, G. H., Barnes, A. A., Emson, P. C., Foord, S. M., & Marshall, F. H. (1998) · Nature · doi:10.1038/25354 · Cited by 1,165
International Union of Pharmacology. XII. Classification of opioid receptors
Bn, D., Cesselin, F., Raghubir, R., Reisine, T., Bradley, P. B., Portoghese, P. S., & Hamon, M. (1996) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06958-3 · Cited by 732
Dimerization: An Emerging Concept for G Protein–Coupled Receptor Ontogeny and Function
Angers, S., Salahpour, A., & Bouvier, M. (2002) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.091701.082314 · Cited by 586
Pharmacological and biochemical interactions between opioids and cannabinoids
Manzanares, J., Corchero, J., Romero, J., Fernández‐Ruíz, J., Ramos, J. A., & Fuentes, J. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01339-5 · Cited by 391
A role for heterodimerization of μ and δ opiate receptors in enhancing morphine analgesia
Gomes, I., Gupta, A., Filipovska, J., Szeto, H. H., Pintar, J. E., & Devi, L. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307601101 · Cited by 386
Self-citation
Ultrastructural Localization of the CB1 Cannabinoid Receptor in μ-Opioid Receptor Patches of the Rat Caudate Putamen Nucleus
Rodriguez, J. J., Mackie, K., & Pickel, V. M. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-03-00823.2001 · Cited by 372
Oligomerization of opioid receptors with beta 2-adrenergic receptors: A role in trafficking and mitogen-activated protein kinase activation
Jordan, B. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.011384898 · Cited by 328

Flagged first, then by citations

Show all 42 references

Sorted by citations

Items 101–200 of 328

Driving the need to feed: Insight into the collaborative interaction between ghrelin and endocannabinoid systems in modulating brain reward systems
Edwards, A., & Abizaid, A. B. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.03.032 · Cited by 54
Targeting Cannabinoid 1 and Delta Opioid Receptor Heteromers Alleviates Chemotherapy-Induced Neuropathic Pain
Sierra, S., Gupta, A., Gomes, I., Fowkes, M. E., Ram, A., Bobeck, E. N., & Devi, L. A. (2019) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.9b00008 · Cited by 47
Self-citation
Heterodimerization of human apelin and bradykinin 1 receptors: Novel signal transduction characteristics
Bai, B., Liu, L., Zhang, N., Wang, C., Jiang, Y., & Chen, J. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.03.022 · Cited by 45
The effectiveness of self-directed medical cannabis treatment for pain
Li, X., Vigil, J. M., Stith, S. S., Brockelman, F., Keeling, K., & Hall, B. (2019) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2019.07.022 · Cited by 47
In vivoopioid receptor heteromerization: where do we stand?
Massotte, D. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12702 · Cited by 44
Differential Response to Morphine of the Oligomeric State of μ-Opioid in the Presence of δ-Opioid Receptors
Golebiewska, U. P., Johnston, J. M., Devi, L. A., Filizola, M., & Scarlata, S. (2011) · Biochemistry · doi:10.1021/bi101701x · Cited by 45
Self-citation
Gi/o-Coupled Receptors Compete for Signaling to Adenylyl Cyclase in SH-SY5Y Cells and Reduce Opioid-Mediated cAMP Overshoot
Levitt, E. S., Purington, L. C., & Traynor, J. R. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.064816 · Cited by 43
Effect of endocannabinoid signalling on cell fate: life, death, differentiation and proliferation of brain cells
Garcı́a-Arencibia, M., Molina‐Holgado, E., & Molina‐Holgado, F. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14369 · Cited by 45
Human orexin/hypocretin receptors form constitutive homo- and heteromeric complexes with each other and with human CB1 cannabinoid receptors
Jäntti, M. H., Mandrika, I., & Kukkonen, J. P. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.02.026 · Cited by 41
Receptor-regulated Interaction of Activator of G-protein Signaling-4 and Gαi
Öner, Ş. S., Maher, E. M., Breton, B., Bouvier, M., & Blumer, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.c109.088070 · Cited by 41
Natural intracellular peptides can modulate the interactions of mouse brain proteins and thimet oligopeptidase with 14‐3‐3ε and calmodulin
Russo, L. C., Asega, A. F., de Castro, L. M., Negraes, P. D., Cruz, L., Gozzo, F. C., Ulrich, H., de Camargo, A. C. M., Rioli, V., & Ferro, E. S. (2012) · PROTEOMICS · doi:10.1002/pmic.201200032 · Cited by 41
Antagonism of Dopamine Receptor 2 Long Affects Cannabinoid Receptor 1 Signaling in a Cell Culture Model of Striatal Medium Spiny Projection Neurons
Bagher, A. M., Laprairie, R. B., Kelly, M. E. M., & Denovan‐Wright, E. M. (2016) · Molecular Pharmacology · doi:10.1124/mol.116.103465 · Cited by 41
Functions of the Chemokine Receptor CXCR4 in the Central Nervous System and Its Regulation by μ-Opioid Receptors
Nash, B., & Meucci, O. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801284-0.00005-1 · Cited by 40
Delineation of Domains Within the Cannabinoid CB1 and Dopamine D2 Receptors That Mediate the Formation of the Heterodimer Complex
Khan, S. S., & Lee, F. J. S. (2013) · Journal of Molecular Neuroscience · doi:10.1007/s12031-013-0181-7 · Cited by 39
Oligomerization of GPCRs involved in endocrine regulation
Kleinau, G., Müller, A., & Biebermann, H. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-16-0049 · Cited by 41
Heteromerization Modulates mu Opioid Receptor Functional Properties in vivo
Ugur, M., Derouiche, L., & Massotte, D. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01240 · Cited by 43
Patient-reported outcomes in those consuming medical cannabis: a prospective longitudinal observational study in chronic pain patients
Meng, H., Pagé, M. G., Ajrawat, P., Deshpande, A., Samman, B., Dominicis, M., Ladha, K. S., Fiorellino, J., Huang, A., Kotteeswaran, Y., et al. (2021) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-020-01903-1 · Cited by 42
Noladin ether, a putative endocannabinoid, inhibits μ-opioid receptor activation via CB2 cannabinoid receptors
Páldyová, E., Bereczki, E., Sántha, M., Wenger, T., Borsodi, A. D., & Benyhe, S. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.06.033 · Cited by 39
Involvement of cannabinoid (CB1)-receptors in the development and maintenance of opioid tolerance
Trang, T., Sutak, M., & Jhamandas, K. H. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.02.031 · Cited by 39
Autocrine Endocannabinoid Signaling through CB1 Receptors Potentiates OX1 Orexin Receptor Signaling
Jäntti, M. H., Putula, J., Turunen, P. M., Näsman, J., Reijonen, S., Lindqvist, C., & Kukkonen, J. P. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.080523 · Cited by 39
Crosstalk between the M1 muscarinic acetylcholine receptor and the endocannabinoid system: A relevance for Alzheimer's disease?
Thompson, K. J., & Tobin, A. B. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109545 · Cited by 39
Co-expression of the human cannabinoid receptor coding region splice variants (hCB1) affects the function of hCB1 receptor complexes
Bagher, A. M., Laprairie, R. B., Kelly, M. E. M., & Denovan‐Wright, E. M. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.09.002 · Cited by 37
Novel orally available salvinorin A analog PR-38 protects against experimental colitis and reduces abdominal pain in mice by interaction with opioid and cannabinoid receptors
Sałaga, M., Polepally, P. R., Zakrzewski, P. K., Cygankiewicz, A. I., Sobczak, M., Kordek, R., Zjawiony, J. K., Krajewska, W. M., & Fichna, J. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.09.018 · Cited by 37
Gi-protein–coupled 5-HT1B/D receptor agonist sumatriptan induces type I hyperalgesic priming
Araldi, D., Ferrari, L. F., & Levine, J. D. (2016) · Pain · doi:10.1097/j.pain.0000000000000581 · Cited by 37
Blockade of neuronal dopamine D2 receptor attenuates morphine tolerance in mice spinal cord
Dai, W., Xiong, F., Yan, B., Cao, Z., Liu, W., Liu, J.-H., & Yu, B. (2016) · Scientific Reports · doi:10.1038/srep38746 · Cited by 37
Orexin Receptor Multimerization versus Functional Interactions: Neuropharmacological Implications for Opioid and Cannabinoid Signalling and Pharmacogenetics
Thompson, M. D., Sakurai, T., Rainero, I., Maj, M. C., & Kukkonen, J. P. (2017) · Pharmaceuticals · doi:10.3390/ph10040079 · Cited by 37
Therapeutic potential of opioid/cannabinoid combinations in humans: Review of the evidence
Babalonis, S. L., & WALSH, S. L. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.03.002 · Cited by 39
Adolescent Exposure to Chronic Delta-9-Tetrahydrocannabinol Blocks Opiate Dependence in Maternally Deprived Rats
Morel, L. J., Bruno Giros, A., & Daugé, V. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.70 · Cited by 37
Functional diversity on synaptic plasticity mediated by endocannabinoids
Cachope, R. (2012) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0386 · Cited by 37
The prescription of medical cannabis by a transitional pain service to wean a patient with complex pain from opioid use following liver transplantation: a case report
Meng, H., Hanlon, J. G., Katznelson, R., Ghanekar, A., McGilvray, I. D., & Clarke, H. A. (2015) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-015-0525-6 · Cited by 36
Influence of three-day morphine-treatment upon impairment of memory consolidation induced by cannabinoid infused into the dorsal hippocampus in rats
Zarrindast, M., Navaeian, M., & Nasehi, M. M. (2010) · Neuroscience Research · doi:10.1016/j.neures.2010.09.007 · Cited by 36
Interactions between Δ9-tetrahydrocannabinol and heroin
Li, J., Koek, W., & France, C. P. (2012) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32835a3907 · Cited by 36
Reciprocal inhibition of G-protein signaling is induced by CB1 cannabinoid and GABAB receptor interactions in rat hippocampal membranes
Çınar, R., Freund, T. F., Katona, I., Mackie, K., & Szűcs, M. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2008.02.005 · Cited by 36
The endocannabinoid system is modulated in reward and homeostatic brain regions following diet-induced obesity in rats: a cluster analysis approach
Bourdy, R., Hertz, A., Filliol, D., Andry, V., Goumon, Y., Mendoza, J., Olmstead, M. C., & Befort, K. (2021) · European Journal of Nutrition · doi:10.1007/s00394-021-02613-0 · Cited by 38
Monoglyceride lipase deficiency causes desensitization of intestinal cannabinoid receptor type 1 and increased colonic μ‐opioid receptor sensitivity
Taschler, U., Eichmann, T. O., Radner, F. P. W., Grabner, G. F., Wolinski, H., Storr, M., Lass, A., Schicho, R., & Zimmermann, R. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13224 · Cited by 35
Attenuation of morphine antinociceptive tolerance by cannabinoid CB1 and CB2 receptor antagonists
Altun, A., Yıldırım, K., Özdemir, E., Bağcıvan, İ., Gürsoy, S., & Durmuş, N. (2015) · The Journal of Physiological Sciences · doi:10.1007/s12576-015-0379-2 · Cited by 34
Biological Significance of GPCR Heteromerization in the Neuro-Endocrine System
Kamal, M. T., & Jockers, R. (2011) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00002 · Cited by 34
Disease-Specific Heteromerization of G-Protein-Coupled Receptors That Target Drugs of Abuse
Gomes, I., Fujita, W., Chandrakala, M. V., & Devi, L. A. (2013) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-386931-9.00009-x · Cited by 35
Self-citation
Effects of acute low-dose combined treatment with naloxone and AM 251 on food intake, feeding behaviour and weight gain in rats
Tallett, A. J., Blundell, J. E., & Rodgers, R. J. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.08.007 · Cited by 33
Endogenous opioids and cannabinoids: System interactions in the regulation of appetite, grooming and scratching
Tallett, A. J., Blundell, J. E., & Rodgers, R. J. (2008) · Physiology & Behavior · doi:10.1016/j.physbeh.2008.02.009 · Cited by 33
Structural analysis of the human cannabinoid receptor one carboxyl‐terminus identifies two amphipathic helices
Ahn, K. H., Pellegrini, M., Tsomaia, N., Yatawara, A. K., Kendall, D. A., & Mierke, D. F. (2009) · Biopolymers · doi:10.1002/bip.21179 · Cited by 32
Antibodies Against G-Protein Coupled Receptors: Novel Uses in Screening and Drug Development
Gupta, A., Heimann, A. S., Gomes, I., & Devi, L. A. (2008) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/138620708784911465 · Cited by 32
Self-citation
CB1 Receptor-Independent Actions of SR141716 on G-Protein Signaling: Coapplication with the μ-Opioid Agonist Tyr-d-Ala-Gly-(NMe)Phe-Gly-ol Unmasks Novel, Pertussis Toxin-Insensitive Opioid Signaling in μ-Opioid Receptor-Chinese Hamster Ovary Cells
Çınar, R., & Szűcs, M. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.152710 · Cited by 32
Multifunctional Opioid Ligands
Anand, J. P., & Montgomery, D. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_104 · Cited by 31
Evidence for Differential Regulation of GnRH Signaling via Heterodimerization among GnRH Receptor Paralogs in the Protochordate, Ciona intestinalis
Sakai, T., Aoyama, M., Kawada, T., Kusakabe, T. G., Tsuda, M., & Satake, H. (2012) · Endocrinology · doi:10.1210/en.2011-1668 · Cited by 31
Receptome: Interactions between three pain-related receptors or the “Triumvirate” of cannabinoid, opioid and TRPV1 receptors
Zádor, F., & Wollemann, M. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.10.015 · Cited by 30
In vivo mapping of a GPCR interactome using knockin mice
Degrandmaison, J., Abdallah, K., Blais, V., Génier, S., Lalumière, M.-P., Bergeron, F., Cahill, C. M., Boulter, J., Lavoie, C. L., Parent, J., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1917906117 · Cited by 30
The inverse agonist effect of rimonabant on G protein activation is not mediated by the cannabinoid CB1 receptor: Evidence from postmortem human brain
Erdozain, A. M., Dı́ez-Alarcia, R., Meana, J. J., & Callado, L. F. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.10.018 · Cited by 31
Cellular and behavioral basis of cannabinioid and opioid interactions: Implications for opioid dependence and withdrawal
Mohammadkhani, A., & Borgland, S. L. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24770 · Cited by 29
Interaction of Endocannabinoid Receptors with Biological Membranes
Dainese, E., Oddi, S., & Maccarrone, M. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790980087 · Cited by 29
Cannabinoid receptor trafficking in peripheral cells is dynamically regulated by a binary biochemical switch
Kleyer, J., Nicolussi, S., Taylor, P., Simonelli, D., Furger, E., Anderle, P., & Gertsch, J. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.02.014 · Cited by 29
Modulation of extracellular signal-regulated kinase (ERK) by opioid and cannabinoid receptors that are expressed in the same cell
Korzh, A., Keren, O., Gafni, M., Bar-Josef, H., & Sarne, Y. (2008) · Brain Research · doi:10.1016/j.brainres.2007.10.070 · Cited by 33
CB1 receptors modulate the intake of a sweetened-fat diet in response to mu-opioid receptor stimulation of the nucleus accumbens
Skelly, M. J., Guy, E. G., Howlett, A. C., & Pratt, W. E. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.05.024 · Cited by 29
Receptor mechanisms underlying the CNS effects of cannabinoids: CB1 receptor and beyond
Hempel, B. J., & Xi, Z. (2022) · Advances in pharmacology · doi:10.1016/bs.apha.2021.10.006 · Cited by 29
Cardiotoxic effects of common and emerging drugs: role of cannabinoid receptors
Bo, Y., Zhao, X., & Li, L. (2024) · Clinical Science · doi:10.1042/cs20231156 · Cited by 30
Opioid and cannabinoid receptors: friends with benefits or just close friends?
Christie, M. J. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706756 · Cited by 28
Naltrexone does not attenuate the effects of intravenous Δ9-tetrahydrocannabinol in healthy humans
Ranganathan, M., Carbuto, M., Braley, G., Elander, J., Perry, E. B., Pittman, B. P., Radhakrishnan, R., Sewell, R. A., & D’Souza, D. C. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001830 · Cited by 27
Opioid‐sparing effects of cannabinoids on morphine analgesia: participation of CB 1 and CB 2 receptors
Chen, X., Cowan, A., Inan, S., Geller, E. B., Meissler, J. J., Rawls, S. M., Tallarida, R. J., Tallarida, C. S., Watson, M. N., Adler, M. W., et al. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14769 · Cited by 27
Functional characterization of G-protein-coupled receptors: A bioinformatics approach
Tovo‐Rodrigues, L., Roux, A., Hutz, M. H., Rohde, L. A., & Woods, A. S. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.06.049 · Cited by 27
Effect of acute and continuous morphine treatment on transcription factor expression in subregions of the rat caudate putamen. Marked modulation by D4 receptor activation
Gago, B., Suárez‐Boomgaard, D., Fuxé, K., Brené, S., Reina‐Sánchez, M. D., Rodríguez‐Pérez, L., Agnati, L. F., de la Calle, A., & Rivera, A. (2011) · Brain Research · doi:10.1016/j.brainres.2011.06.046 · Cited by 27
The Involvement of the Endocannabinoid System in the Peripheral Antinociceptive Action of Ketamine
Ferreira, R. C. M., Castor, M. G. M. E., Piscitelli, F., Marzo, V. D., Duarte, I. D. G., & Romero, T. R. L. (2017) · Journal of Pain · doi:10.1016/j.jpain.2017.12.002 · Cited by 26
Structural properties and role of the endocannabinoid lipases ABHD6 and ABHD12 in lipid signalling and disease
Kind, L., & Kursula, P. (2018) · Amino Acids · doi:10.1007/s00726-018-2682-8 · Cited by 28
DARK Classics in Chemical Neuroscience: Salvinorin A
Hernández-Alvarado, R. B., Madariaga‐Mazón, A., Ortega, A. R., & Martínez‐Mayorga, K. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00608 · Cited by 27
The Endocannabinoid System and Its Role in Regulating the Intrinsic Neural Circuitry of the Gastrointestinal Tract
Trautmann, S. M., & Sharkey, K. A. (2015) · International review of neurobiology · doi:10.1016/bs.irn.2015.10.002 · Cited by 27
PnPP‐19, a spider toxin peptide, induces peripheral antinociception through opioid and cannabinoid receptors and inhibition of neutral endopeptidase
Freitas, A. C. N., Pacheco, D. F., Machado, M. F. M., Carmona, A. K., Duarte, I. D. G., & de Lima, M. E. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13448 · Cited by 26
Alleviative effects of Cannabis flower on migraine and headache
Stith, S. S., Diviant, J. P., Brockelman, F., Keeling, K., Hall, B., Lucern, S., & Vigil, J. M. (2020) · Journal of Chinese Integrative Medicine · doi:10.1016/j.joim.2020.07.004 · Cited by 26
Two Affinity Sites of the Cannabinoid Subtype 2 Receptor Identified by a Novel Homogeneous Binding Assay
Martínez‐Pinilla, E., Rabal, O., Reyes‐Resina, I., Zamarbide, M., Navarro, G., Sánchez-Arias, J. A., de Miguel, I., Lanciego, J. L., Oyarzábal, J., & Franco, R. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.234948 · Cited by 25
Neuronal signaling repertoire in the mammalian sperm functionality
Ramírez‐Reveco, A., Villarroel‐Espíndola, F., Rodríguez-Gil, J. E., & Concha, I. I. (2017) · Biology of Reproduction · doi:10.1095/biolreprod.116.144154 · Cited by 27
Two to tango: GPCR oligomers and GPCR-TRP channel interactions in nociception
Yekkirala, A. S. (2013) · Life Sciences · doi:10.1016/j.lfs.2012.06.021 · Cited by 24
Brain endocannabinoid signaling exhibits remarkable complexity
Gorzkiewicz, A., & Szemraj, J. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.06.012 · Cited by 26
Cannabinoid receptor CB1 and CB2 interacting proteins: Techniques, progress and perspectives
Oyagawa, C. R. M., & Grimsey, N. L. (2021) · Methods in cell biology · doi:10.1016/bs.mcb.2021.06.011 · Cited by 25
Cannabinoid-dependent potentiation of inhibition at eye opening in mouse V1
Garkun, Y., & Maffei, A. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00046 · Cited by 24
Binge sucrose-induced neuroadaptations: A focus on the endocannabinoid system
Nogueira, D. D. S., Bourdy, R., Filliol, D., Awad, G., Andry, V., Goumon, Y., Olmstead, M. C., & Befort, K. (2021) · Appetite · doi:10.1016/j.appet.2021.105258 · Cited by 25
Ketamine induces central antinociception mediated by endogenous cannabinoids and activation of CB1 receptors
Pacheco, D. D. F., Romero, T. R. L., & Duarte, I. D. G. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.01.059 · Cited by 23
Therapeutic potential of opioid receptor heteromers in chronic pain and associated comorbidities
Gaborit, M., & Massotte, D. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15772 · Cited by 22
Interactions between cannabinoid receptor agonists and mu opioid receptor agonists in rhesus monkeys discriminating fentanyl
Maguire, D. R., & France, C. P. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.05.018 · Cited by 22
Functional blockage of the cannabinoid receptor type 1 evokes a kappa‐opiate‐dependent analgesia
Sáez-Cassanelli, J. L., Fontanella, G. H., Delgado-Garcia, J. M., & Carrión, Á. M. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05000.x · Cited by 22
Chronic cannabinoid exposure produces tolerance to the dopamine releasing effects of WIN 55,212–2 and heroin in adult male rats
Gomez, D. M., Everett, T. J., Hamilton, L. R., Ranganath, A., Cheer, J. F., & Oleson, E. B. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108374 · Cited by 21
Regulation of Corticostriatal Synaptic Plasticity by G Protein-Coupled Receptors
de Maturana, R. L., & Sánchez‐Pernaute, R. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710793361531 · Cited by 21
A spider derived peptide, PnPP-19, induces central antinociception mediated by opioid and cannabinoid systems
Pacheco, D. D. F., Freitas, A. C. N., Pimenta, A. M. C., Duarte, I. D. G., & de Lima, M. E. (2016) · The Journal of venomous animals and toxins including tropical diseases · doi:10.1186/s40409-016-0091-6 · Cited by 21
Consequences of opioid receptor mutation on actions of univalent and bivalent kappa and delta ligands
Ansonoff, M. A., Portoghese, P. S., & Pintar, J. E. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1826-7 · Cited by 21
CB1-independent mechanisms of Δ9-THCV, AM251 and SR141716 (rimonabant)
Raffa, R. B., & Ward, S. J. (2011) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2011.01284.x · Cited by 21
Inhibition of forebrain μ-opioid receptor signaling by low concentrations of rimonabant does not require cannabinoid receptors and directly involves μ-opioid receptors
Zádor, F., Ötvös, F., Benyhe, S., Zimmer, A., & Páldy, E. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.05.015 · Cited by 20
Antibodies that identify only the active conformation of G i family G protein α subunits
Lane, J. R., Henderson, D., Powney, B., Wise, A., Rees, S., Daniels, D. A., Plumpton, C., Kinghorn, I. J., & Milligan, G. (2008) · The FASEB Journal · doi:10.1096/fj.07-100388 · Cited by 20
Oligomerization of MrgC11 and μ-opioid receptors in sensory neurons enhances morphine analgesia
He, S.-Q., Xu, Q., Tiwari, V., Yang, F., Anderson, M. C., Chen, Z., Grenald, S. A., Raja, S. N., Dong, X., & Guan, Y. (2018) · Science Signaling · doi:10.1126/scisignal.aao3134 · Cited by 20
Somatostatin receptor 5 is a prominent regulator of signaling pathways in cells with coexpression of Cannabinoid receptors 1
Zou, S., Somvanshi, R. K., & Kumar, U. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.10.056 · Cited by 20
Constitutive Activity at the Cannabinoid CB1 Receptor and Behavioral Responses
Hanlon, K. E., & Vanderah, T. W. (2010) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-381298-8.00001-0 · Cited by 19
Allosteric Modulation of the Cannabinoid CB1 Receptor
Cawston, E. E., Hunter, M. R., & Glass, M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-800756-3.00070-3 · Cited by 19
Interaction of Cannabis Use and Aging: From Molecule to Mind
Yoo, H. B., DiMuzio, J. M., & Filbey, F. M. (2019) · Journal of Dual Diagnosis · doi:10.1080/15504263.2019.1665218 · Cited by 21
Strain differences in the expression of endocannabinoid genes and in cannabinoid receptor binding in the brain of Lewis and Fischer 344 rats
Coria, S. M., Roura‐Martínez, D., Ucha, M., Assis, M. A., Miguéns, M., Garcı́a-Lecumberri, C., Higuera‐Matas, A., & Ambrosio, E. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.02.012 · Cited by 19
Regulation of ERK1/2 phosphorylation by acute and chronic morphine – implications for the role of cAMP‐responsive element binding factor (CREB)‐dependent and Ets‐like protein‐1 (Elk‐1)‐dependent transcription; small interfering RNA‐based strategy
Ligeza, A., Wawrzczak‐Bargieła, A., Kamińska, D., Korostyński, M., & Przewłocki, R. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06531.x · Cited by 20
Low dose naloxone attenuates the pruritic but not anorectic response to rimonabant in male rats
Wright, F., & Rodgers, R. J. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2916-5 · Cited by 18
Positive allosteric modulation of the cannabinoid type-1 receptor (CB1R) in periaqueductal gray (PAG) antagonizes anti-nociceptive and cellular effects of a mu-opioid receptor agonist in morphine-withdrawn rats
Datta, U., Kelley, L. K., Middleton, J. W., & Gilpin, N. W. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05650-5 · Cited by 18
Noncanonical Activity of Endocannabinoids and Their Receptors in Central and Peripheral Synapses
Balezina, O. P., Tarasova, E. O., & Gaydukov, A. E. (2021) · Biochemistry (Moscow) · doi:10.1134/s0006297921070038 · Cited by 18
On the G-Protein-Coupled Receptor Heteromers and Their Allosteric Receptor-Receptor Interactions in the Central Nervous System: Focus on Their Role in Pain Modulation
Borroto‐Escuela, D. O., Romero‐Fernandez, W., Rivera, A., Craenenbroeck, K. V., Tarakanov, A. O., Agnati, L. F., & Fuxé, K. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/563716 · Cited by 17
Integration and Spatial Organization of Signaling by G Protein-Coupled Receptor Homo- and Heterodimers
Maggio, R., Fasciani, I., Carli, M., Petragnano, F., Marampon, F., Rossi, M., & Scarselli, M. (2021) · Biomolecules · doi:10.3390/biom11121828 · Cited by 18
Antinociception mechanisms of action of cannabinoid-based medicine: an overview for anesthesiologists and pain physicians
Narouze, S. (2020) · Regional Anesthesia & Pain Medicine · doi:10.1136/rapm-2020-102114 · Cited by 18
Orally Active Peptide Vector Allows Using Cannabis to Fight Pain While Avoiding Side Effects
Gallo, M., Moreno, E., Defaus, S., Ortega-Álvaro, A., González, Á., Robledo, P., Cavaco, M. C., Neves, V., Castanho, M. A. R. B., Casadó, V., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00484 · Cited by 18
Alternative Interacting Sites and Novel Receptors for Cannabinoid Ligands
Köfalvi, A. (2007) · Springer eBooks · doi:10.1007/978-0-387-74349-3_9 · Cited by 17
Clinical implications for cannabinoid use in the rheumatic diseases: Potential for help or harm?
Fitzcharles, M., McDougall, J. J., Ste‐Marie, P. A., & Padjen, I. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34522 · Cited by 16

Authors: Rios, C., Gomes, I., & Devi, L. A.
Affiliations: Cornell University (US)
Icahn School of Medicine at Mount Sinai (US)
Corresponding author: Devi, Lakshmi A
ORCID: Gomes, Ivone
Devi, Lakshmi A
Venue: British Journal of Pharmacology
Publisher: Wiley
Published: 2006-06
Volume: 148
Issue: 4
Pages: 387-395
ISSN: 0007-1188 (ISSN-L)
1476-5381
DOI: 10.1038/sj.bjp.0706757
PMC: PMC1751792
OpenAlex: W1487872499
Cited by: 327
References: 42
Citations by year: 2026: 7 · 2025: 14 · 2024: 13 · 2023: 7 · 2022: 10 · 2021: 16 · 2020: 17 · 2019: 15 · 2018: 11 · 2017: 15 · 2016: 16 · 2015: 9 · 2014: 18 · 2013: 21 · 2012: 25
FWCI: 14.41
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 973 d)
Locations: British Journal of Pharmacology (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (DA08863)
National Institute on Drug Abuse (DA 08863, K05DA019521, R56DA008863, R37DA008863, DA19521, R01DA008863)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
Keywords: mu-opioid receptor, CB1 receptor, receptor-receptor interactions, opioid-cannabinoid interaction, neurite outgrowth, bioluminescence resonance energy transfer, CCR5 chemokine receptor, MAPK phosphorylation, Src phosphorylation, STAT3 phosphorylation, N2a cells
MeSH terms: Cells, Cultured, Humans, Phosphorylation, Signal Transduction, Guanosine 5'-O-(3-Thiotriphosphate), Neurites, Receptors, Opioid, mu, Enkephalin, Ala(2)-MePhe(4)-Gly(5)-, Receptor, Cannabinoid, CB1, Extracellular Signal-Regulated MAP Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

μ opioid and CB1 cannabinoid receptor interactions: reciprocal inhibition of receptor signaling and neuritogenesis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks